BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shallis RM, Stahl M, Bewersdorf JP, Hendrickson JE, Zeidan AM. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits. Expert Rev Hematol 2020;13:489-99. [PMID: 32248712 DOI: 10.1080/17474086.2020.1751609] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Shao YD, Wang XH, Sun L, Cui XG. Granulocytic sarcoma with long spinal cord compression: A case report. World J Clin Cases 2022; 10(31): 11536-11541 [DOI: 10.12998/wjcc.v10.i31.11536] [Reference Citation Analysis]
2 Wolf J, Thomas I, Stanworth S, Knapper S, Griffin J. Leukocytapheresis in the management of adults with acute myeloid leukaemia: A survey of AML treating centres highlighting variability in practice. Transfus Med 2022. [PMID: 36260030 DOI: 10.1111/tme.12929] [Reference Citation Analysis]
3 Arad-Cohen N, Zeller B, Abrahamsson J, Fernandez Navarro JM, Cheuk D, Palmu S, Costa V, De Moerloose B, Hasle H, Jahnukainen K, Pronk CJ, Gísli Jónsson Ó, Kovalova Z, Lausen B, Munthe-Kaas M, Noren-Nyström U, Palle J, Pasauliene R, Saks K, Kaspers GJ. Supportive care in pediatric acute myeloid leukemia:expert-based recommendations of the NOPHO-DB-SHIP consortium. Expert Rev Anticancer Ther 2022. [PMID: 36191604 DOI: 10.1080/14737140.2022.2131544] [Reference Citation Analysis]
4 Mei N, Su H, Gong S, Du H, Zhang X, Wang L, Wang H. High CX3CR1 expression predicts poor prognosis in paediatric acute myeloid leukaemia undergoing hyperleukocytosis. Int J Lab Hematol 2022. [PMID: 36064206 DOI: 10.1111/ijlh.13963] [Reference Citation Analysis]
5 Cotorogea-Simion M, Pavel B, Isac S, Telecan T, Matache IM, Bobirca A, Bobirca FT, Rababoc R, Droc G. What Is Different in Acute Hematologic Malignancy-Associated ARDS? An Overview of the Literature. Medicina (Kaunas) 2022;58:1215. [PMID: 36143892 DOI: 10.3390/medicina58091215] [Reference Citation Analysis]
6 Brunker PAR, Bailey JA. Therapeutic phlebotomy and cellular hemapheresis. Rossi's Principles of Transfusion Medicine 2022. [DOI: 10.1002/9781119719809.ch26] [Reference Citation Analysis]
7 Xu A, Liu P, Zhou F, Teekaraman Y. Analysis of Risk Factors of Coagulation Dysfunction and Hemorrhage in Newly Diagnosed Hyperleukocytic Acute Myeloma Leukemia. Contrast Media & Molecular Imaging 2022;2022:1-8. [DOI: 10.1155/2022/7828230] [Reference Citation Analysis]
8 Spring J, Munshi L. Hematology Emergencies in Adults With Critical Illness. Chest 2022;162:120-131. [DOI: 10.1016/j.chest.2022.02.004] [Reference Citation Analysis]
9 Rinaldi I, Sutandyo N, Winston K. Comparison of early mortality between leukapheresis and non-leukapheresis in adult acute myeloid leukemia patients with hyperleukocytosis: a systematic review and meta-analysis. Hematology 2022;27:141-9. [DOI: 10.1080/16078454.2021.2024939] [Reference Citation Analysis]
10 Zhang D, Zhu Y, Jin Y, Kaweme NM, Dong Y. Leukapheresis and Hyperleukocytosis, Past and Future. Int J Gen Med 2021;14:3457-67. [PMID: 34285568 DOI: 10.2147/IJGM.S321787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ngo RT, Webb McAdams AL, Furiato A. Acute Myeloid Leukemia Complicated by Hyperleukocytosis and Leukostasis in the Emergency Department. Cureus 2021;13:e15392. [PMID: 34094792 DOI: 10.7759/cureus.15392] [Reference Citation Analysis]
12 Zhao J, Bewersdorf JP, Jaszczur S, Kowalski A, Perreault S, Schiffer M, Gore S, Podoltsev N, Prebet T, Shallis R, Zeidan AM. High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis. Leuk Lymphoma 2021;62:1195-202. [PMID: 33325761 DOI: 10.1080/10428194.2020.1856835] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Bewersdorf JP, Zeidan AM. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments? Cells 2020;9:E2310. [PMID: 33080779 DOI: 10.3390/cells9102310] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
14 Bewersdorf JP, Giri S, Tallman MS, Zeidan AM, Stahl M. Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia—A systematic review and meta‐analysis. Transfusion 2020;60:2360-9. [DOI: 10.1111/trf.15994] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]